Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46461
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZemskova, V. A.-
dc.contributor.authorZoloedov, V. I.-
dc.contributor.authorPopova, O. A.-
dc.date.accessioned2022-04-28T10:18:20Z-
dc.date.available2022-04-28T10:18:20Z-
dc.date.issued2017-
dc.identifier.citationZemskova, V.A. Optimization immunepharmacotherapy of pyoinflammatory diseases / V.A. Zemskova, V.I. Zoloedov, O.A. Popova // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol. 3, № 4.- P. 160-176. - Doi: 10.18413/2313-8971-2017-3-4-160-176. - Refer.: p. 176ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/46461-
dc.description.abstractThe results of clinical investigation of several pyoinflammatory diseases are presented. Objectives: On clinical data of various models of pyoinflammatory diseases - deep pyodermia (UCP), chronic salpingooforitis (OHSO), chronic pyelonephritis (CPN), authors found a significant mechanism of influence the pathogenesis on the manifestation of immunopathology, efficacy and mechanisms of pharmacological immunocorrection actionru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subjectbiologyru
dc.subjectzoologyru
dc.subjectphysiology of animalsru
dc.subjectpyoinflammatory diseasesru
dc.subjectimmunotherapyru
dc.subjectimmunological disordersru
dc.subjectformalized assessmentru
dc.titleOptimization immunepharmacotherapy of pyoinflammatory diseasesru
dc.typeArticleru
Appears in Collections:Vol. 3, № 4

Files in This Item:
File Description SizeFormat 
Zemskova_Optimization_17.pdf3.17 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.